We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

129 hedge funds and large institutions have $363M invested in Keryx Biopharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 36

2% less funds holding

Funds holding: 132 → 129 (-3)

11% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 27

34% less call options, than puts

Call options by funds: $3.96M | Put options by funds: $5.98M

36% less capital invested

Capital invested by funds: $563M → $363M (-$201M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
129
Holders Change
-3
Holders Change %
-2.27%
% of All Funds
2.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
24
Increased
42
Reduced
36
Closed
27
Calls
$3.96M
Puts
$5.98M
Net Calls
-$2.02M
Net Calls Change
-$310K

Top Buyers

Rank Fund Capital Flow
1
ACM
Abrams Capital Management
Massachusetts
+$22M
2
State Street
State Street
Massachusetts
+$12.1M
3
CLM
ClearBridge LLC (Maryland)
Maryland
+$5.99M
4
Ameriprise
Ameriprise
Minnesota
+$2.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.81M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$37.1M
2
Millennium Management
Millennium Management
New York
-$10.3M
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$5.36M
4
CCP
Clough Capital Partners
Massachusetts
-$5.33M
5
MPAM
Monarch Partners Asset Management
Massachusetts
-$4.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAC
126
Certified Advisory Corp
Florida
$2K +$2.48K +450 New
FANJ
127
Financial Architects (New Jersey)
New Jersey
$1K – – –
GRP
128
Global Retirement Partners
California
$1K +$1.32K +240 New
CCM
129
Consonance Capital Management
New York
– -$37.1M -5,229,455 Closed
Millennium Management
130
Millennium Management
New York
– -$10.3M -1,444,625 Closed
Russell Investments Group
131
Russell Investments Group
United Kingdom
– -$5.36M -754,631 Closed
CCP
132
Clough Capital Partners
Massachusetts
– -$5.33M -751,101 Closed
MPAM
133
Monarch Partners Asset Management
Massachusetts
– -$4.87M -685,700 Closed
EI
134
EAM Investors
California
– -$1.53M -214,898 Closed
KCM
135
Knoll Capital Management
Florida
– -$1.42M -200,000 Closed
TCM
136
Timpani Capital Management
Wisconsin
– -$1.37M -192,756 Closed
SSA
137
Schonfeld Strategic Advisors
New York
– -$711K -100,120 Closed
Point72 Asset Management
138
Point72 Asset Management
Connecticut
– -$710K -100,000 Closed
QIM
139
Quantitative Investment Management
Virginia
– -$473K -66,700 Closed
NFA
140
Nationwide Fund Advisors
Ohio
– -$360K -50,732 Closed
Wolverine Trading
141
Wolverine Trading
Illinois
– -$257K -46,677 Closed
MFIM
142
Mesirow Financial Investment Management
Illinois
– -$284K -40,014 Closed
GAM
143
Gotham Asset Management
New York
– -$258K -36,288 Closed
CSS
144
Cubist Systematic Strategies
Connecticut
– -$164K -23,040 Closed
VF
145
Virtu Financial
New York
– -$145K -20,473 Closed
EGM
146
Engineers Gate Manager
New York
– -$102K -14,300 Closed
FRM
147
Fox Run Management
Connecticut
– -$101K -14,200 Closed
AG
148
Aperio Group
California
– -$94K -13,226 Closed
AZA
149
Arthur Zaske & Associates
Michigan
– -$86K -12,103 Closed
N
150
Natixis
France
– -$79K -11,164 Closed
3 4 5
6
7

KERX Hedge Fund Activity: Q4 2017 in Review

129 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q4 2017, worth a combined $363M — down 36% from $563M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of KERX and 24 opened new positions — a net loss of 3 holders — while 36 trimmed existing stakes and 42 added.

The largest buyer was Abrams Capital Management, adding an estimated $22M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $37.1M sold.

  • 129 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q4 2017, down from 132 in Q3 2017.
  • Funds reported $363M of Keryx Biopharmaceuticals Inc stock for Q4 2017, down 36% quarter-over-quarter.
  • 24 funds opened new Keryx Biopharmaceuticals Inc positions in Q4 2017 and 27 closed out, a net change of -3 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q4 2017 was Abrams Capital Management, an estimated $22M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q4 2017 was Consonance Capital Management, an estimated $37.1M sold.

Based on aggregated 13F filings for Q4 2017.